人类白细胞抗原错配对儿童肾移植结局影响的系统评价与荟萃分析
结果显示,与0-1个HLA-DR错配相比,2个错配显著增加1年、3年、5年和10年移植失败风险;HLA-A+B 2-4个错配较0-1个错配增加5年移植失败风险。
要点
- HLA-DR 2个错配较0-1个错配显著增加儿童肾移植1、3、5、10年移植失败风险。
- HLA-A+B 2-4个错配较0-1个错配增加5年移植失败风险(RR 3.17)。
- HLA-A+B 3-4个错配较0-2个错配的5年移植失败风险无显著差异。
核心结论
- HLA-DR和HLA-A+B错配是影响儿童肾移植受者移植后结局尤其是移植失败的重要因素。
研究设计与样本
- 采用随机效应模型合并风险比(RR)及95%置信区间(CI)。
主要发现
- 与0-1个HLA-DR错配相比,2个错配增加1年移植失败风险(RR 1.41,95%CI 1.11-1.80)。
- 与0-1个HLA-DR错配相比,2个错配增加3年移植失败风险(RR 1.28,95%CI 1.08-1.52)。
- 与0-1个HLA-DR错配相比,2个错配增加5年移植失败风险(RR 1.21,95%CI 1.04-1.41)。
- 与0-1个HLA-DR错配相比,2个错配增加10年移植失败风险(RR 1.30,95%CI 1.02-1.67)。
- HLA-A+B 2-4个错配较0-1个错配增加5年移植失败风险(RR 3.17,95%CI 1.20-8.36)。
关键数值与推荐
- HLA-DR错配2个 vs 0-1个:1年移植失败RR 1.41(95%CI 1.11-1.80)。
- HLA-DR错配2个 vs 0-1个:3年移植失败RR 1.28(95%CI 1.08-1.52)。
- HLA-DR错配2个 vs 0-1个:5年移植失败RR 1.21(95%CI 1.04-1.41)。
- HLA-DR错配2个 vs 0-1个:10年移植失败RR 1.30(95%CI 1.02-1.67)。
- HLA-A+B错配2-4个 vs 0-1个:5年移植失败RR 3.17(95%CI 1.20-8.36)。
临床怎么用
- 在儿童肾移植评估中应重视HLA-DR和HLA-A+B错配数量对长期移植失败风险的影响。
- 尽可能减少HLA-DR错配(尤其是避免2个错配)以降低移植失败风险。
- HLA-A+B错配2-4个时需加强术后监测和免疫抑制管理。
局限性
- 纳入研究均为队列研究,证据级别有限。
- 需要更多高质量随机对照试验进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Kidney transplantation is regarded as the optimal treatment for pediatric patients with end-stage renal disease. Here, we address a controversial topic in pediatric kidney transplantation by performing a quantitative evaluation of the effect of human leukocyte antigen (HLA) mismatching on the outcomes of pediatric kidney transplantation. METHODS: We systematically searched PubMed, EMBASE and the Cochrane Library from their inception to 31 December 2016 for cohort studies assessing the risk ratio (RR) of HLA mismatching on pediatric kidney transplantation. Outcome measures included graft failure, rejection and all-cause mortality. RRs and 95% confidence intervals (CIs) were used as estimates of effect size in random-effect models. RESULTS: Eighteen studies comprising a total of 26 018 pediatric recipients were included in the evaluation. Compared with 0-1 HLA-DR mismatch, 2 mismatches significantly increased the risk of graft failure at 1 year (RR: 1.41, 95% CI: 1.11-1.80), 3 years (RR: 1.28, 95% CI: 1.08-1.52), 5 years (RR: 1.21, 95% CI: 1.04-1.41) and 10 years (RR: 1.30, 95% CI: 1.02-1.67). For HLA-A + B, the 5-year graft failure risk was higher for 2-4 mismatches compared with 0-1 mismatch (RR: 3.17, 95% CI: 1.20-8.36), but not for 3-4 compared with 0-2 mismatches (RR: 1.49, 95% CI: 0.79-2.80). CONCLUSIONS: Based on pooled analysis, HLA-DR and HLA-A + B are important factors affecting post-transplant outcomes, especially graft failure, in pediatric recipients. Additional randomized controlled trials with higher quality evidence are needed for further investigation.
引用
- Shi X, Liu R, Xie X, et al. Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017. PMID: 28992320. doi:10.1093/ndt/gfx259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。